Beigene Ltd ADR (NQ: BGNE )
245.18
-11.72
(-4.56%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2023
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
BeiGene to Present at Upcoming Investor Conferences
February 01, 2023
4 Analysts Have This to Say About BeiGene
January 20, 2023
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
BeiGene Earnings Perspective: Return On Capital Employed
December 12, 2022
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
Five Best And Worst Performing Healthcare Stocks In December 2022
January 22, 2023
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
January 19, 2023
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
December 08, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|